Peptide PilotPeptide Pilot

Vial duration

BPC-157 vial duration calculator

Estimate how many weeks one 5 mg BPC-157 vial covers at your dose and weekly cadence.

Download Peptide PilotiPhone · Free to download

Total doses

20

Lasts

2.9 weeks

BPC-157 is a peptide people use to speed up recovery from soft-tissue injuries — tendons, ligaments, muscle strains, and gut-lining irritation. In animal studies it consistently accelerated tendon and muscle healing versus saline controls, often by promoting new blood-vessel growth at the injury site. Human clinical data is limited, so most reports are anecdotal. This page covers reconstitution math, typical daily logging cadence, and common mistakes.

How the BPC-157 vial duration calculator works

This calculator answers the inventory question: at your current dose and weekly cadence, how many weeks will this BPC-157 vial last? It is the math you need to plan refills before a vial runs dry mid-protocol — especially with peptides like GLP-1s where shipping windows can run several weeks.

The formula is two divisions. Total doses per vial equals vial mg divided by dose mg, rounded down. Weeks of supply equals total doses divided by doses per week. With a 5 mg vial of BPC-157, a 0.25 mg dose, and 7 dose per week, the vial covers 20 doses, or about 2.9 weeks of supply.

The three inputs that move the answer: vial mg (set when you bought the vial), dose mg (set by your protocol step), and doses-per-week (set by the peptide's half-life). Once a vial is reconstituted it also has a stability ceiling — most lyophilized peptides reconstituted in BAC water are typically used within four to six weeks of refrigerated storage, so a vial that mathematically lasts twelve weeks may not last twelve weeks in practice.

Use this calculator before opening a new vial to confirm the dose and cadence you have planned will not strand you halfway through. Use it again whenever you titrate up — a dose increase shortens vial life, sometimes dramatically. The calculator is intentionally conservative: it floors total doses, never assumes partial-dose draws, and never extends weeks beyond what whole doses support.

BPC-157 cadence and how it changes vial life

Daily subcutaneous injection is the default cadence in most BPC-157 logs, and twice-daily protocols also appear. Doses are small enough that a U-100 insulin syringe is the standard tool.

Cycling — running BPC-157 for a defined number of weeks, then taking a break — is common in personal logs. Recording the start and stop date of each cycle in the log is what makes the timeline auditable later.

Some users inject BPC-157 close to a target area; others prefer rotating standard subcutaneous sites. Either way, recording the injection site in the log is what surfaces site-rotation patterns over time.

A unique consideration when planning a documentation schedule for BPC-157 is the administration route. While subcutaneous injection is common in peptide research, a significant body of preclinical literature on BPC-157 also explores oral administration. This dual-route exploration makes it a critical variable to log for accurate personal tracking. If a protocol involves subcutaneous administration, precise dose calculation is necessary. For example, a 5 mg vial reconstituted with 2 mL of bacteriostatic water yields a concentration of 2,500 mcg/mL. A 250 mcg illustrative dose is 0.1 mL or 10 units on a U-100 syringe. This dose would be logged with a daily cadence, explicitly noting the administration route (e.g., 'Subcutaneous, left thigh') to distinguish it from any potential oral use.

Storage and shelf life for BPC-157

Lyophilized BPC-157 powder is generally stored refrigerated until reconstitution. The in-use reconstituted vial is typically kept refrigerated and used within several weeks. Marking the reconstitution date directly on the vial avoids the common case of finding an unmarked vial later and not knowing whether it is still in its useful window.

Tracking BPC-157 vials in a real log

Daily peptides like BPC-157 are where logging discipline matters most: the cadence is high, the doses are small, and the easiest mistake is double-dosing or skipping after losing track of the day. A timestamped dose log removes that ambiguity entirely.

The daily administration cadence often documented for BPC-157 makes meticulous injection site rotation tracking particularly important. Repeated subcutaneous injections at the same anatomical location can lead to palpable changes in the underlying subcutaneous fat tissue, a condition known as lipohypertrophy. To properly monitor for such changes, a detailed site rotation log is invaluable. A simple and effective method is to mentally divide the abdomen into four quadrants (upper-right, lower-right, upper-left, lower-left) and rotate through them systematically. Other potential sites like the deltoids, thighs, and glutes can also be incorporated into the rotation. Accurately recording the date and location of every injection allows an individual to audit their protocol and correlate any observed skin or tissue irregularities with their administration history.

Common BPC-157 vial-planning mistakes

  • Typing a milligram value into the calculator with the toggle still set to micrograms — produces a unit count 1000x too high.
  • Forgetting whether the morning dose was already taken on a twice-daily protocol — almost always a logging gap, not a math problem.
  • Reading 250 mcg as 25 units regardless of vial concentration. The unit count depends on diluent volume.
  • Reusing the previous vial's unit count after switching to a new vial reconstituted with a different volume.
  • Letting reconstituted BPC-157 sit at room temperature on travel days when a small cooler would have kept it cold.
  • Not recording the injection site, which makes site-rotation patterns invisible weeks later.
  • Failing to document the administration route, since both oral and subcutaneous methods are explored in research literature, making the route a critical variable.
  • Neglecting to log a detailed site rotation schedule, which makes it difficult to monitor for lipohypertrophy that can be observed with daily injections.
  • Assuming BPC-157 and TB-500 follow the same logging cadence when tracked as a stack, which can lead to inaccurate and conflated records.

Frequently asked questions about BPC-157 vial duration

Why does the BPC-157 calculator default to micrograms?
Because typical illustrative doses are well below 1 mg, and typing 250 mcg is much less error-prone than typing 0.25 mg. The mg-mcg toggle is still available if the protocol you are following is framed in milligrams.
How is BPC-157 reconstituted?
Add a measured volume of bacteriostatic water through the rubber stopper, then swirl — not shake — until the lyophilized powder fully dissolves. A 5 mg vial with 2 mL of BAC water gives a concentration of 2,500 mcg per mL.
How many units of BPC-157 are in 250 mcg?
On a 5 mg vial reconstituted with 2 mL of bacteriostatic water (2,500 mcg per mL), 250 mcg is exactly 10 units on a U-100 insulin syringe. On a 5 mg vial with 1 mL of BAC water, the same dose is 5 units.
Is BPC-157 dosed daily?
Daily and twice-daily protocols are both common in personal logs. The cadence makes consistent logging especially valuable, because the easiest mistake on a daily peptide is losing track of whether a dose has already been taken.
How long does a 5 mg BPC-157 vial last?
At a 250 mcg daily dose, a 5 mg vial provides 20 doses — about 2.9 weeks of daily supply. The vial duration calculator runs the math for any combination of vial size, dose, and frequency.
Does BPC-157 need to be refrigerated?
Lyophilized powder is typically stored refrigerated, and the reconstituted vial is kept refrigerated and used within several weeks. Writing the reconstitution date on the vial helps prevent using a long-opened vial past its useful life.
Should every injection site be recorded?
Recording the site is what surfaces rotation patterns weeks later. Peptide Pilot includes a site picker for exactly this reason — clicking a body diagram is faster than typing the location and produces cleaner trend data.
What is the structural origin of BPC-157?
BPC-157 is a peptide fragment with the 15-amino-acid sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. It is not a naturally occurring peptide on its own, but rather a synthetic copy of a sequence isolated from a larger protein called Body Protection Compound found in human gastric juice. Its unusual structure, particularly its proline-rich core, is studied for its potential role in the peptide's high stability.
Why is the administration route a critical variable to track for BPC-157?
Unlike many peptides that are almost exclusively studied via injection, BPC-157 has been explored in animal research through both subcutaneous and oral administration routes. Because the delivery method is a fundamental variable that influences how a substance is absorbed and distributed, it is a critical data point to log. Tracking whether a dose was administered orally or via injection is essential for maintaining an accurate and auditable personal record over time.
How does tracking a BPC-157 and TB-500 'stack' differ from tracking them individually?
Tracking these two peptides in a stack requires managing two distinct schedules within a single log. Research protocols for BPC-157 often involve a daily administration cadence. In contrast, TB-500 (or its active fragment) is typically documented with a less frequent schedule, such as twice-weekly. A proper log must record each administration event separately, noting the specific peptide, dose, and date to accurately observe any patterns or outcomes without conflating the effects of two different protocols.

Related on Peptide Pilot

Track BPC-157 vials automatically

Download on the App Store
Get the App